How should I manage a pediatric patient with prolonged menstrual bleeding who initially improved on ferrous sulfate, then had recurrent heavy flow after 3 weeks, and experienced heavier bleeding on day 2 after starting medroxyprogesterone acetate (Provera)?

Immediate Management: Stop Provera and Switch to High-Dose Estrogen

Stop the Provera immediately and initiate high-dose combined oral contraceptives (COCs) or estrogen therapy to control the acute heavy bleeding, as progestin-only therapy (like Provera) can paradoxically worsen bleeding in the acute setting. 1

Why Provera Made Bleeding Worse

Progestin-only therapy like medroxyprogesterone acetate (Provera) is designed for chronic management of anovulatory bleeding, not acute hemorrhage. When given during active heavy bleeding, progestins can cause:

• Breakthrough bleeding due to inadequate endometrial support
• Worsening of existing heavy flow
• Unpredictable bleeding patterns 1

The guidelines explicitly state that for heavy or prolonged bleeding, hormonal treatment should use low-dose COCs or estrogen for short-term treatment (10-20 days), NOT progestin alone 1.

Correct Acute Management Protocol

Step 1: Immediate Bleeding Control (Days 1-7)

• Start high-dose combined oral contraceptives: Give one pill three times daily for 7 days 2
• Alternative if COCs contraindicated: High-dose conjugated estrogen 2.5 mg orally every 4-6 hours until bleeding stops (usually 24-48 hours), then taper 2
• Add NSAIDs (ibuprofen 600-800 mg three times daily) during bleeding days for 5-7 days 1

Step 2: Stabilization Phase (Days 8-21)

• Continue COCs at regular dosing (one pill daily) to stabilize the endometrium
• Continue iron supplementation (ferrous sulfate 325 mg daily) 3

Step 3: Maintenance (After Acute Episode)

Once bleeding is controlled, choose based on patient needs:

If contraception needed:

• Continue COCs long-term 2
• Consider 17β-estradiol-based COCs (with nomegestrol acetate or dienogest) as first choice in adolescents 4

If contraception NOT needed:

• Cyclic progestin therapy: Medroxyprogesterone acetate 10 mg daily for days 16-25 of cycle for at least 3-6 months 2
• This prevents recurrence by inducing regular withdrawal bleeds

Critical Evaluation Needed NOW

Before continuing any therapy, evaluate for:

• Hemoglobin level: If <7 g/dL or hemodynamically unstable, consider hospitalization 5
• Underlying bleeding disorder: Von Willebrand disease is present in ~1% of population and commonly presents as HMB in adolescents 2, 6
• Pregnancy test: Must rule out pregnancy complications 7
• Coagulation studies: PT, PTT, von Willebrand panel if not previously done 6

Why This Patient Failed Initial Management

The recurrence after 3 weeks on iron alone suggests:

1. Anovulatory cycles causing unstable endometrium (common in adolescents)
2. Possible underlying bleeding disorder not yet diagnosed 6
3. Iron alone does NOT control bleeding—it only treats anemia 3

Common Pitfall to Avoid

Never use progestin-only therapy (Provera, norethindrone) as first-line for acute heavy bleeding. This is the most common error in managing adolescent HMB. Progestins are for prevention of future episodes, not acute control 1, 2.

The evidence shows high-dose progestin (60-120 mg medroxyprogesterone on day 1, then 20 mg daily) can work for acute bleeding 8, but this requires much higher doses than standard Provera prescribing and is less effective than estrogen-based therapy 2.

Hematology Consultation

Given the severity (requiring two medication changes, recurrent bleeding), consult pediatric hematology to evaluate for bleeding disorders before the next menstrual cycle 5, 6. This is a missed opportunity in most adolescents with HMB, leading to diagnostic delays averaging years 6.